ESNR / 2nd Advanced Course in Diagnostic Neuroradiology - Glioma Imaging
You are using an outdated version of Internet Explorer. Some functionalities of this website may get lost due to this. Please update your browser or use an alternative like Chrome, Firefox or Safari.

Dear Colleagues,

It is my great pleasure to invite you to the second edition of the advanced, level III course on Glioma Imaging.

Neurooncology is one of the areas that has benefited most from the tremendous advances in MR imaging and its powerful techniques. Recent progress in understanding tumour biology have deeply influenced the way in which gliomas are classified. They are also transforming their surgical and medical management.

This course will address these important and exciting developments and the impact on the early diagnosis on gliomas, the pre- and intra-operative planning and the post-operative monitoring in terms of clinical management, clinical trials and experimental therapies. The program of this second edition has been improved and completed thanks to the precious feedback coming from the 130 worldwide participants of the first edition held in November 2017. In particular, the duration of the course has been extended to allow more time for discussion, clinical case sessions have been implemented at the end of all frontal sessions, the variety of work-stations for hands-on session workshops has been increased to provide access to the main systems commercially available for data post-processing.

The course will be again held at the San Raffaele Congress Centre in Milan (Italy). San Raffaele is a clinical research university hospital established in 1971 to provide international-level specialized care for the most complex and difficult health conditions. The university is the top-rated medical school in Italy and is one of the few Italian universities in biomedical research where there is a close interaction between basic and clinical research units, hospital divisions and teaching. The Neuroradiology Department has a long-standing expertise in the field of clinical and experimental oncology.

Milan is a great industrial city in the north of Italy, rich in history, art and monuments. During the last ten years, the city has developed new exciting areas that have added interest to the classical attractions and the well-known fashion area.

I am sure that together with the top-level faculty, San Raffaele and Milan will contribute to creating the proper context for a successful and rewarding course.

I very much look forward to welcoming you to Milan next January.

Prof. Andrea Falini

Course Director